Amgen (AMGN) PT Raised to $250 at Oppenheimer

December 2, 2019 7:46 AM EST Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $250.00 (from $240.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login